IBDEI2DS ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37998,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,37999,0)
 ;;=L98.0^^146^1925^21
 ;;^UTILITY(U,$J,358.3,37999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37999,1,3,0)
 ;;=3^Pyogenic granuloma
 ;;^UTILITY(U,$J,358.3,37999,1,4,0)
 ;;=4^L98.0
 ;;^UTILITY(U,$J,358.3,37999,2)
 ;;=^5009574
 ;;^UTILITY(U,$J,358.3,38000,0)
 ;;=L40.0^^146^1925^16
 ;;^UTILITY(U,$J,358.3,38000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38000,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,38000,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,38000,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,38001,0)
 ;;=L40.1^^146^1925^19
 ;;^UTILITY(U,$J,358.3,38001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38001,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,38001,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,38001,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,38002,0)
 ;;=L40.9^^146^1925^17
 ;;^UTILITY(U,$J,358.3,38002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38002,1,3,0)
 ;;=3^Psoriasis, unspec
 ;;^UTILITY(U,$J,358.3,38002,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,38002,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,38003,0)
 ;;=L40.3^^146^1925^20
 ;;^UTILITY(U,$J,358.3,38003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38003,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,38003,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,38003,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,38004,0)
 ;;=L40.8^^146^1925^15
 ;;^UTILITY(U,$J,358.3,38004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38004,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,38004,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,38004,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,38005,0)
 ;;=L40.4^^146^1925^18
 ;;^UTILITY(U,$J,358.3,38005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38005,1,3,0)
 ;;=3^Psoriasis,Guttate
 ;;^UTILITY(U,$J,358.3,38005,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,38005,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,38006,0)
 ;;=M72.2^^146^1925^9
 ;;^UTILITY(U,$J,358.3,38006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38006,1,3,0)
 ;;=3^Plantar fascial fibromatosis
 ;;^UTILITY(U,$J,358.3,38006,1,4,0)
 ;;=4^M72.2
 ;;^UTILITY(U,$J,358.3,38006,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,38007,0)
 ;;=M15.9^^146^1925^10
 ;;^UTILITY(U,$J,358.3,38007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38007,1,3,0)
 ;;=3^Polyosteoarthritis,Unspec
 ;;^UTILITY(U,$J,358.3,38007,1,4,0)
 ;;=4^M15.9
 ;;^UTILITY(U,$J,358.3,38007,2)
 ;;=^5010768
 ;;^UTILITY(U,$J,358.3,38008,0)
 ;;=I87.002^^146^1925^13
 ;;^UTILITY(U,$J,358.3,38008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38008,1,3,0)
 ;;=3^Postthrom syndr w/o compl of lft lwr extrem
 ;;^UTILITY(U,$J,358.3,38008,1,4,0)
 ;;=4^I87.002
 ;;^UTILITY(U,$J,358.3,38008,2)
 ;;=^5008028
 ;;^UTILITY(U,$J,358.3,38009,0)
 ;;=I73.9^^146^1925^2
 ;;^UTILITY(U,$J,358.3,38009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38009,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,38009,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,38009,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,38010,0)
 ;;=M06.372^^146^1926^13
 ;;^UTILITY(U,$J,358.3,38010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38010,1,3,0)
 ;;=3^Rheumatoid nodule, left Ankle/Foot
 ;;^UTILITY(U,$J,358.3,38010,1,4,0)
 ;;=4^M06.372
 ;;^UTILITY(U,$J,358.3,38010,2)
 ;;=^5010116
 ;;^UTILITY(U,$J,358.3,38011,0)
 ;;=M06.371^^146^1926^14
 ;;^UTILITY(U,$J,358.3,38011,1,0)
 ;;=^358.31IA^4^2
